The biotech sector has thrown up a high number of gems over…
3 Biotech Stocks Jumped Big Last Month
Browsing Tag
TLSA
8 posts
Stock Price Newsletter – September 16, 2019
Tiziana Life Sciences (TLSA) Announces FDA Approval to Initiate Phase I Clinical…
Tiziana Life Sciences (TLSA) Announces FDA Approval to Initiate Phase I Clinical Trial with Orally Administered Foralumab in Healthy Volunteers
A breakthrough approach for treatment of autoimmune and inflammatory diseases London, 16…
Stock Price Newsletter – Tuesday, September 10, 2019
Tuesday’s packed full of big breaking news. Right now several key sectors…
Multi-Billion Dollar Markets Are Ready For A Shake-Up; 1 Biotech Stock Could Hold The Key
Tiziana Life Sciences (TLSA) Could Hold Humira’s Kryptonite There’s no denying that…
This Biotech Stock Could Hold the Key to a Multi-Billion Dollar Market Shake-up
Biotech is One of the Hottest Sectors & Can Provide the Largest…
Stock Price Thursday Morning Update – September 5, 2019
Has 1 Biotech Company Found Humira’s Kryptonite? More times than not, biotechnology…
Tiziana Life Sciences (TLSA) Reports Positive Phase 2a Clinical Data Exhibiting Positive Clinical Activity with Milciclib Monotherapy in Advanced Sorafenib-refractory or -intolerant Patients with Unresectable or Metastatic Hepatocellular Carcinoma
NEW YORK–(BUSINESS WIRE)– Tiziana Life Sciences plc (TLSA), a biotechnology company focusing…